PIX-R
Dead / Cancelled — Cancelled — Section 8 (as of 30 Nov 2018)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85199935
- Registration number
- 4132743
- Mark type
- Stylized text
- Filed
- 16 Dec 2010
- Published for opposition
- 03 May 2011
- Registered
- 24 Apr 2012
- Attorney of record
- Frances M. Jagla
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research, namely, conducting clinical trials for pharmaceutical preparations used for the treatment of cancer
Owner
- CTI BIOPHARMA CORP., SEATTLE, WA, US
- Cell Therapeutics, Inc., Seattle, WA, US
- Cell Therapeutics, Inc., Seattle, WA, US
- Cell Therapeutics, Inc., Seattle, WA, US
Prosecution history
- 30 Nov 2018 — CANCELLED SEC. 8 (6-YR)
- 24 Apr 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 May 2016 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 May 2016 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Jul 2014 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 24 Apr 2012 — REGISTERED-PRINCIPAL REGISTER
- 22 Mar 2012 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Mar 2012 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 19 Mar 2012 — ASSIGNED TO LIE
- 02 Mar 2012 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Feb 2012 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Jan 2012 — USE AMENDMENT FILED
- 07 Feb 2012 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Jan 2012 — TEAS STATEMENT OF USE RECEIVED
- 22 Dec 2011 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED